Jones Financial Companies
AUPH icon

Jones Financial Companies’s Aurinia Pharmaceuticals AUPH Stock Holding History

Jones Financial Companies’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.8K Sell
1,037
-633
-38% -$9.25K ﹤0.01% 3423
2025
Q4 		$26.6K Buy
1,670
+55
+3% +$780 ﹤0.01% 2817
2025
Q3 		$21.2K Sell
1,615
-200
-11% -$2.18K ﹤0.01% 2771
2025
Q2 		$15.7K Hold
1,815
– – ﹤0.01% 2708
2025
Q1 		$15K Buy
1,815
+200
+12% +$1.62K ﹤0.01% 2534
2024
Q4 		$14.5K Buy
+1,615
New +$13.2K ﹤0.01% 2380
2024
Q3 		– Sell
-700
Closed -$4K – 3022
2024
Q2 		$4K Buy
+700
New +$3.69K ﹤0.01% 1992

Other funds holding AUPH

TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jones Financial Companies's AUPH Position: Q1 2026 in Review

Jones Financial Companies reduced its Aurinia Pharmaceuticals (AUPH) stake by 38% in Q1 2026, selling an estimated $9.25K and leaving 1,037 shares worth $14.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3423.

Jones Financial Companies first reported a position in AUPH in Q2 2024 and has held it in 7 quarters since. The position peaked at $26.6K in Q4 2025. 259 funds tracked by Wall St. Rank hold AUPH as of Q1 2026.

  • Jones Financial Companies held 1,037 shares of Aurinia Pharmaceuticals worth $14.8K as of Q1 2026.
  • Jones Financial Companies sold 633 Aurinia Pharmaceuticals shares in Q1 2026, an estimated $9.25K.
  • Aurinia Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3423 holding.
  • Jones Financial Companies first reported a position in Aurinia Pharmaceuticals in Q2 2024 and has held it in 7 quarters since.
  • Jones Financial Companies's Aurinia Pharmaceuticals position peaked at $26.6K in Q4 2025.
  • 259 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.